New Advances in Utilizing Microparticle Drug Delivery Systems for Targeted, Intra-articular Drug Therapy in Osteoarthritis
Madeline Franke Introduction: Osteoarthritis (OA) is a debilitating, degenerative joint disease that affects approximately 250 million people worldside1. OA is a leading cause of physical disability and its risk increases with factors such as age, obesity, and joint injury1,2. OA involves a mismatch between the anabolism and catabolism of cartilage…